This review addresses the pathophys

This review addresses the pathophysiology and treatment of hemorrhagic shock – a condition
produced by rapid and significant loss of intravascular volume, which may lead sequentially to
hemodynamic instability, decreases in oxygen delivery, decreased tissue perfusion, cellular hypoxia,
organ damage, and death. Hemorrhagic shock can be rapidly fatal. The primary goals are to stop the
bleeding and to restore circulating blood volume. Resuscitation may well depend on the estimated
severity of hemorrhage. It now appears that patients with moderate hypotension from bleeding may
benefit by delaying massive fluid resuscitation until they reach a definitive care facility. On the other
hand, the use of intravenous fluids, crystalloids or colloids, and blood products can be life saving in
those patients who are in severe hemorrhagic shock. The optimal method of resuscitation has not been
clearly established. A hemoglobin level of 7–8 g/dl appears to be an appropriate threshold for
transfusion in critically ill patients with no evidence of tissue hypoxia. However, maintaining a higher
hemoglobin level of 10 g/dl is a reasonable goal in actively bleeding patients, the elderly, or individuals
who are at risk for myocardial infarction. Moreover, hemoglobin concentration should not be the only
therapeutic guide in actively bleeding patients. Instead, therapy should be aimed at restoring
intravascular volume and adequate hemodynamic parameters.

ผลลัพธ์ (อังกฤษ) 2:

This review addresses the Pathophysiology and Treatment of hemorrhagic Shock - a condition
produced by Rapid and significant Loss of intravascular volume, which sequentially May Lead to
hemodynamic instability, decreases in Oxygen Delivery, Decreased tissue perfusion, Cellular hypoxia,
organ damage, and Death. Hemorrhagic shock can be rapidly fatal. The primary goals are to Stop the
bleeding and to Restore Blood circulating volume. May Depend on the estimated resuscitation well
Severity of hemorrhage. It now appears that patients with moderate hypotension bleeding from May
Benefit by delaying Massive Fluid resuscitation until they reach a Definitive Care facility. On the Other
Hand, the use of intravenous Fluids, crystalloids or colloids, and Blood Products Can be Life Saving in
those patients are in severe hemorrhagic Who Shock. The Optimal method of resuscitation has not been
established Clearly. A hemoglobin level of 7-8 G / DL appears to be an appropriate threshold for
transfusion in Critically ill patients with no Evidence of tissue hypoxia. However, maintaining a higher
hemoglobin level of 10 G / DL is a reasonable Goal in actively bleeding patients, the elderly, or individuals
at risk for myocardial infarction Who are. Moreover, hemoglobin concentration should not be the only
therapeutic Guide in actively bleeding patients. Instead, Therapy should be aimed at Restoring
intravascular volume and adequate hemodynamic Parameters.

ผลลัพธ์ (อังกฤษ) 3:

This review addresses the pathophysiology and treatment of hemorrhagic shock - a condition
produced by rapid and significant. Loss of intravascular volume which may, lead sequentially to
hemodynamic instability decreases in oxygen delivery decreased,,, Perfusion tissue, hypoxia cellular, organ damage
, death and. Hemorrhagic shock can be rapidly fatal. The primary goals are. To stop the
.Bleeding and to restore circulating blood volume. Resuscitation may well depend on the estimated
severity of, hemorrhage. It now appears that patients with moderate hypotension from bleeding may
benefit by delaying massive fluid resuscitation. Until they reach a definitive care facility. On the other
hand the use, of intravenous fluids crystalloids or colloids,,And blood products can be life saving in
those patients who are in severe hemorrhagic shock. The optimal method of resuscitation. Has not been
clearly established. A hemoglobin level of 7 - 8 g / dl appears to be an appropriate threshold for
transfusion. In critically ill patients with no evidence of tissue hypoxia. However maintaining a, higher
.Hemoglobin level of 10 g / dl is a reasonable goal in actively bleeding patients the, individuals, elderly or
who are at. Risk for myocardial infarction. Moreover hemoglobin concentration, should not be the only
therapeutic guide in actively. Bleeding patients. Instead therapy should, be aimed at restoring
intravascular volume and adequate hemodynamic parameters.